Mineralocorticoid Receptor Antagonists (MRAs): More Attention Required (To Prescription)!

Kardiologia Polska - Poland
doi 10.5603/kp.2018.0182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Polskie Towarzystwo Kardiologiczne

Related search

Third-Generation Mineralocorticoid Receptor Antagonists

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2016English

Mineralocorticoid Receptor Antagonists for Heart Failure

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2011English

Managing Resistant Hypertension: Focus on Mineralocorticoid-Receptor Antagonists

Vascular Health and Risk Management
2017English

Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2016English

Mineralocorticoid Receptor Antagonists: New Extended Roles in Cardio- And Nephroprotection

Medical Council
2018English

Mineralocorticoid Receptor Antagonists for Heart Failure: Systematic Review and Meta-Analysis

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Mineralocorticoid Receptor Antagonists for Heart Failure: A Real-Life Observational Study

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Mineralocorticoid Receptor Antagonists Attenuate Exaggerated Exercise Pressor Reflex Responses in Hypertensive Rats

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2017English

No Need for Urgent Revisiting of Kalaemia Levels in Guidelines Despite Use of Mineralocorticoid Receptor Antagonists: Bring in More Evidence

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy